On August 5, 2024, the Company received a letter from the NASDAQ Hearings Panel that, following the Company’s hearing before the Panel on July 23, 2024, NASDAQ has determined to delist the Company’s common stock and that trading in the Company’s securities will be suspended from NASDAQ at the open of trading on August 7, 2024. It is anticipated that the Company’s common stock will be subject to quotation and trading on the over-the-counter market as of August 7, 2024 under the Company’s existing trading symbol “SPEC.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPEC:
- Spectaire Holdings announces initial delivery of 500 AireCore unit order
- Spectaire Announces Initial Delivery of a 500 AireCore Unit Order with $5 Million Annual Recurring Revenue Potential
- Spectaire Holdings Enhances Board with UPS Veteran
- Spectaire Holdings announces upcoming release of AireCore 2.0
- Spectaire Unveils AireCore 2.0: Opening New Revenue Opportunities in Pharmaceuticals, Environmental Analysis, and Advanced Materials Research